sign out privacy and data protectionhelp pages submission ...€¦ · 27/04/2016 18/08/2016 no <...
TRANSCRIPT
Privacy and Data ProtectionHelp Pages
Submission
Home > Submission
Status Accepted
Open
Date01/10/2016
Deadline
Date31/10/2016
Date
Submitted20/10/2016
Type
Performanc
e in
Initiating
NHS
provider
Northampto
n General
Hospital
NHS Trust
Id
Research
Ethics
Committe
e
Reference
Number
Integrate
d
Researc
h
Applicati
on
System
Number
Submiss
ion TypeName of Trial
Date of
Receipt of
Valid
Research
Application
Date of
NHS
Permission
First
Patient
Recruit
ed?
Submission Details
Sign Out
8699815/SC/031
0167868
NHS
Permissi
on
BOX 3 ? The
Bart?s-Oxford
family study
of childhood
diabetes:
Longitudinal
and multi-
generational
analysis of a
changing
disease
17/12/2015 18/12/2015 Yes
8699914/NW/11
28152982
NHS
Permissi
on
MaPLe ?
Molecular
profiling for
lymphoma
18/11/2015 18/11/2015 Yes
8700015/NW/06
26184626
NHS
Permissi
on
A phase 3,
randomised,
double-blind,
placebo-
controlled,
parallel group,
multi-centre
study to
evaluate the
net clinical
benefit of
Sotagliflozin
as adjunct to
insulin
therapy in
type 1
diabetes
16/12/2015 16/12/2015 Yes
8700115/LO/189
5181595
NHS
Permissi
on
Effective pre-
oxygenation
using high
flow
humidified
nasal oxygen
delivery
system
(EPOD)
23/11/2015 02/12/2015 Yes
8700215/SC/044
3173722
NHS
Permissi
on
OPTIMISE ?
Long term
clear skin
maintenance
treatment
optimisation
in patients
with moderate
to severe
chronic
plaque
psoriasis: A
randomised,
multi-centre,
open-label
with blinded-
assessment,
comparative,
52 week study
to evaluate
the efficacy,
safety and
tolerability of
secukinumab
300 mg s.c.
16/12/2015 16/12/2015 Yes
8700314/SC/017
1120104
NHS
Permissi
on
A phase III,
double blind,
placebo
controlled,
randomised
trial
assessing the
effects of
aspirin on
disease
recurrence
and survival
after primary
therapy in
common non-
metastatic
solid tumours
21/10/2015 22/10/2015 Yes
8700411/SC/052
873866
NHS
Permissi
on
A phase III
multicentre
trial of weekly
induction
chemotherapy
followed by
standard
chemoradiatio
n versus
standard
chemoradiatio
n alone in
patients with
locally
advanced
cervical
cancer
10/12/2015 11/12/2015 Yes
8700515/NI/016
9184948
NHS
Permissi
on
The impact of
severe
hypoglycaemi
c events
requiring
interventions
in patients
with type I
diabetes
patients
treated insulin
therapy
22/10/2015 23/10/2015 Yes
8700612/NW/03
61103977
NHS
Permissi
on
A pragmatic
randomised
controlled
trial
comparing the
effectiveness
and cost
effectiveness
of
levetiracetam
and
zonisamide
versus
standard
treatments for
epilepsy: a
comparison of
Standard and
New
Antiepileptic
Drugs
(SANAD-II)
08/10/2015 08/10/2015 Yes
8700713/NW/00
68115309
NHS
Permissi
on
Investigation
of Factors
Influencing
Psoriatic
Arthritis and
Psoriasis
Response to
Therapy with
Biologic
Drugs
13/10/2015 16/10/2015 Yes
8700811/SW/01
6050632
NHS
Permissi
on
UK Multiple
Sclerosis
Register
08/12/2015 08/12/2015 Yes
8700909/H1008/
13724269
NHS
Permissi
on
The long-term
Safety and
Efficacy of
Biologic
Therapies in
Children with
Rheumatic
Diseases
(BSRBR-JIA)
12/01/2016 13/01/2016 Yes
8701013/EM/045
9137785
NHS
Permissi
on
POSNOC -
POsitive
Sentinel
NOde:
adjuvant
therapy alone
versus
adjuvant
therapy plus
Clearance or
axillary
radiotherapy.
A randomised
controlled
trial of axillary
treatment in
women with
early stage
breast cancer
who have
metastases in
one or two
sentinel
nodes.
13/01/2016 13/01/2016 Yes
8701115/NI/020
7187243
NHS
Permissi
on
Toolkit to
benchmark
young person
friendly
services in
rheumatology
26/02/2016 08/03/2016 Yes
8701214/YH/125
9163195
NHS
Permissi
on
Comparison
of Alitretinoin
with PUVA as
the first line
treatment in
patients with
severe
chronic hand
eczema
(ALPHA)
21/03/2016 22/03/2016 Yes
8701315/EM/049
2189756
NHS
Permissi
on
A
retrospective
real world
research
study to
describe the
use of buccal
midazolam
maleate
(Epistatus®)
in adults in
routine
practice in the
UK
18/01/2016 18/01/2016 Yes
8701414/NW/10
14141897
NHS
Permissi
on
UK CLL
Biobank study07/10/2015 16/11/2015 Yes
8701515/WA/02
41183747
NHS
Permissi
on
A Multicenter,
Randomized,
Double-Blind,
Placebo-
controlled,
Parallel
Group, Phase
3 Study to
Evaluate the
Efficacy and
Safety of
Dapagliflozin
as an Add-on
to Insulin
Therapy in
Subjects with
Type 1
Diabetes
Mellitus -
Study Two
22/03/2016 22/03/2016 Yes
8701615/EE/046
4183877
NHS
Permissi
on
A Phase 3,
Placebo-
Controlled,
Randomized,
Double-Blind,
Multi-Center
Study of LJPC-
501 in
Patients with
Catecholamin
e-Resistant
Hypotension
(CRH)
25/04/2016 27/04/2016 Yes
8701813/SC/064
5143871
NHS
Permissi
on
Pre-eclampsia
in Hospital:
Early
Induction or
Expectant
Management
02/04/2016 02/04/2016 Yes
8896516/SW/01
30203567
NHS
Permissi
on
StartRight:
Getting the
right
classification
and treatment
from
diagnosis in
young adults
with diabetes
14/09/2016 15/09/2016 No
8896714/SW/11
66164941
NHS
Permissi
on
INFORM - A
multicentred
randomised
trial to
compare
1stage with
2stage
revision
surgery for
prosthetic hip
joint infection
13/06/2016 02/08/2016 No
8897016/EM/013
3184873
NHS
Permissi
on
A randomised,
double-blind,
placebo-
controlled
multicentre
study of
secukinumab
to evaluate
the safety,
tolerability
and efficacy
up to 2 years
in patients
with active
nonradiograp
hic axial
spondyloarthr
itis
12/07/2016 11/08/2016 No
8897116/EE/005
3172067
NHS
Permissi
on
AdDIT Follow
Up - Tracking
of risk for
diabetic
nephropathy
and
cardiovascula
r disease in
young people
with Type 1
diabetes
recruited to
the AdDIT
study
06/09/2016 07/09/2016 No
8917414/EM/129
5163111
NHS
Permissi
on
Affinitie: Two
cluster RCTs
to evaluate
feedback in
blood
transfusion
audits
09/05/2016 21/06/2016 No
8917715/LO/220
2190754
NHS
Permissi
on
BOSS - The
British
Orthopaedic
Surgery
Surveillance
Study: A
nationwide
service
evaluation,
and nested-
cohort study.
27/04/2016 18/08/2016 No
< Back
Date of
First
Patient
Recruited
Duration
between
VRA and
NHS
Permissi
on
Duration
between
NHS
Permissi
on and
First
Patient
Duration
between
VRA and
First
Patient
Benchm
ark Met
Date Site
Invited
Date Site
Selected
HRA
Approval
Date
Date Site
Confirm
ed By
Sponsor
Date Site
Confirm
ed
Non-
Confirm
ation
Status
Date Site
Ready
To Start
A -
Permissi
ons
delayed/
denied
B -
Suspend
ed by
sponsor
C -
Closed
by
sponsor
D -
Sponsor
Delays
E - Staff
availabili
ty issues
F - No
patients
seen
G - No
patients
consent
ed
H -
Contract
ing
delays
I - Rare
diseasesJ - Other
Commen
ts
Reasons
for delay
correspo
nd to:
Unknow
n
Please
Select...
Awaiting
sponsor
providin
g a
prescript
ion form
Sponsor
20
patients
recruited
,
recruitm
ent
complet
e
Please
Select...
Unknow
n
Y
Sponsor
initiated
site on
26/11/20
15.
Delays
in
provisio
n of the
imp
caused
delays to
first
patient
recruited
.
Sponsor
Unknow
n
Unknow
n
Sponsor
has
insisted
on
processi
ng an
amendm
ent
before
recruitm
ent
could
commen
ce
Sponsor
Unknow
n
Sub
study
not
available
to
exisiting
patients.
The
delay
between
VRA and
NHSP
was due
to
discrepa
ncies in
version
control
on
paperwo
rk
Sponsor
Unknow
n
Delay as
awaiting
evidence
of rec
approval
for trial
docume
ntation
Sponsor
Site
initiated
14/10/20
16
Sponsor